Identification of human cancers deficient in antigen processing - PubMed (original) (raw)
Identification of human cancers deficient in antigen processing
N P Restifo et al. J Exp Med. 1993.
Abstract
Intracellular antigens must be processed before presentation to CD8+ T cells by major histocompatibility complex (MHC) class I molecules. Using a recombinant vaccinia virus (Vac) to transiently express the Kd molecule, we studied the antigen processing efficiency of 26 different human tumor lines. Three cell lines, all human small cell lung carcinoma, consistently failed to process endogenously synthesized proteins for presentation to Kd-restricted, Vac-specific T cells. Pulse-chase experiments showed that MHC class I molecules were not transported by these cell lines from the endoplasmic reticulum to the cell surface. This finding suggested that peptides were not available for binding to nascent MHC molecules in the endoplasmic reticulum. Northern blot analysis of these cells revealed low to nondetectable levels of mRNAs for MHC-encoded proteasome components LMP-7 and LMP-2, as well as the putative peptide transporters TAP-1 and TAP-2. Treatment of cells with interferon gamma enhanced expression of these mRNAs and reversed the observed functional and biochemical deficits. Our findings suggest that downregulation of antigen processing may be one of the strategies used by tumors to escape immune surveillance. Potential therapeutic applications of these findings include enhancing antigen processing at the level of the transcription of MHC-encoded proteasome and transporter genes.
Similar articles
- Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B, Harders C, Lohmann S, Momburg F, Urlinger S, Tampé R, Huber C. Seliger B, et al. Eur J Immunol. 1998 Jan;28(1):122-33. doi: 10.1002/(SICI)1521-4141(199801)28:01<122::AID-IMMU122>3.0.CO;2-F. Eur J Immunol. 1998. PMID: 9485192 - Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR, et al. Rowe M, et al. Eur J Immunol. 1995 May;25(5):1374-84. doi: 10.1002/eji.1830250536. Eur J Immunol. 1995. PMID: 7774641 - Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
Seliger B, Dunn T, Schwenzer A, Casper J, Huber C, Schmoll HJ. Seliger B, et al. Scand J Immunol. 1997 Dec;46(6):625-32. doi: 10.1046/j.1365-3083.1997.d01-176.x. Scand J Immunol. 1997. PMID: 9420627 - Processing and delivery of peptides presented by MHC class I molecules.
Lehner PJ, Cresswell P. Lehner PJ, et al. Curr Opin Immunol. 1996 Feb;8(1):59-67. doi: 10.1016/s0952-7915(96)80106-3. Curr Opin Immunol. 1996. PMID: 8729447 Review. - Structure and function of genes in the MHC class II region.
Monaco JJ. Monaco JJ. Curr Opin Immunol. 1993 Feb;5(1):17-20. doi: 10.1016/0952-7915(93)90075-4. Curr Opin Immunol. 1993. PMID: 8452671 Review.
Cited by
- Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer.
Chen T, Wang M, Chen Y, Cao Y, Liu Y. Chen T, et al. Cell Biosci. 2024 Sep 12;14(1):117. doi: 10.1186/s13578-024-01283-9. Cell Biosci. 2024. PMID: 39267195 Free PMC article. Review. - Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee.
Monette A, Warren S, Barrett JC, Garnett-Benson C, Schalper KA, Taube JM, Topp B, Snyder A. Monette A, et al. J Immunother Cancer. 2024 Jul 20;12(7):e009427. doi: 10.1136/jitc-2024-009427. J Immunother Cancer. 2024. PMID: 39032943 Free PMC article. Review. - A 15-Gene-Based Risk Signature for Predicting Overall Survival in SCLC Patients Who Have Undergone Surgical Resection.
Atay S. Atay S. Cancers (Basel). 2023 Oct 30;15(21):5219. doi: 10.3390/cancers15215219. Cancers (Basel). 2023. PMID: 37958393 Free PMC article. - CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing.
Liu Z, Liu W, Wang W, Ma Y, Wang Y, Drum DL, Cai J, Blevins H, Lee E, Shah S, Fisher PB, Wang X, Fang X, Guo C, Wang XY. Liu Z, et al. Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2302878120. doi: 10.1073/pnas.2302878120. Epub 2023 Sep 18. Proc Natl Acad Sci U S A. 2023. PMID: 37722058 Free PMC article. - Targeting the loss of cGAS/STING signaling in cancer.
Sasaki N, Homme M, Kitajima S. Sasaki N, et al. Cancer Sci. 2023 Oct;114(10):3806-3815. doi: 10.1111/cas.15913. Epub 2023 Jul 20. Cancer Sci. 2023. PMID: 37475576 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1986 Oct;83(20):7879-82 - PubMed
- J Immunol. 1981 Jun;126(6):2100-3 - PubMed
- Virology. 1987 Oct;160(2):336-45 - PubMed
- J Exp Med. 1987 Dec 1;166(6):1716-33 - PubMed
- Cell. 1988 Mar 25;52(6):843-52 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous